Top Markets
Coin of the day
Imed Infinity Medical-Limited Partnership Imed Infinity Medical-Limited Partnership

Imed Infinity Medical-Limited Partnership

IMED
Rank in Stocks #41438
Operating as a research and development partnership, Imed Infinity... Operating as a research and development partnership, Imed Infinity Medical-Limited Partnership was founded in 2020 and is located in Tel Aviv, Israel. Its central mission involves providing capital for R&D ventures within the medical domain, especially those focused on digital health.
Share Price
$0.30083467
Last synced: 2026-08-04
Market Cap
$20.53K
Change (1 day)
-1.38%
Change (1 year)
-29.10%
Country
IL
Trade Imed Infinity Medical-Limited Partnership (IMED)

Category

P/E ratio for Imed Infinity Medical-Limited Partnership (IMED)
P/E ratio as of 2026 TTM: 0
According to Imed Infinity Medical-Limited Partnership latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Imed Infinity Medical-Limited Partnership from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.